Previous close | 76.97 |
Open | 76.97 |
Bid | 64.59 x 100 |
Ask | 85.24 x 100 |
Day's range | 73.69 - 79.88 |
52-week range | 8.28 - 99.41 |
Volume | |
Avg. volume | 6,623,986 |
Market cap | 8.322B |
Beta (5Y monthly) | 1.10 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Key Insights Significantly high institutional ownership implies Viking Therapeutics' stock price is sensitive to their...
Viking Therapeutics, Inc. (NASDAQ:VKTX) Q1 2024 Earnings Call Transcript April 24, 2024 Viking Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.26, expectations were $-0.27. Viking Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the Viking […]
Q1 2024 Viking Therapeutics Inc Earnings Call